Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Neostigmine Methylsulphate Injection
Neostigmine metilsulfate 2.5mg/mL
Solution for injection
Max Health Limited
Hameln Pharmaceuticals GmbH, Hameln, Germany

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:

Pomalyst
Pomalidomide 1mg
Capsule
Celgene Limited
Celgene International Sarl, Boudry, Switzerland
Penn Pharmaceutical Services Limited, Gwent, United Kingdom

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:

Pomalyst
Pomalidomide 2mg
Capsule
Celgene Limited
Celgene International Sarl, Boudry, Switzerland
Penn Pharmaceutical Services Limited, Gwent, United Kingdom

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:

Pomalyst
Pomalidomide 3mg
Capsule
Celgene Limited
Celgene International Sarl, Boudry, Switzerland
Penn Pharmaceutical Services Limited, Gwent, United Kingdom

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:

Pomalyst
Pomalidomide 4mg
Capsule
Celgene Limited
Celgene International Sarl, Boudry, Switzerland
Penn Pharmaceutical Services Limited, Gwent, United Kingdom

Dated this 12th day of March 2015.

SARAH READER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).